Market revenue in 2023 | USD 8.3 million |
Market revenue in 2030 | USD 50.7 million |
Growth rate | 29.4% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 54.22% in 2023. Horizon Databook has segmented the Brazil artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
Growing inclination toward automating & computationally prepared information to maintain a single point of access for facilitating patient databases, increasing prevalence of chronic diseases, and rising demand for reduced costs & time for drug discovery & development.
AI solutions in drug discovery. Advancements in digital healthcare are expected to drive the demand for modern healthcare services in Brazil. The government is investing significantly in the implementation of AI in the healthcare system.
For instance, the government announced its plans for the establishment of eight R&D AI labs. One lab would focus on cybersecurity and seven R&D centers would operate on developments pertaining to the country’s IoT plan, which is centered on its four main verticals healthcare, agribusiness, manufacturing, & smart cities.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Brazil artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account